Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial

T Kolk; H van der Wall; GK Hogendoorn; R Rijneveld; S Luijten; DCJG van Alewijk; EHA van den Munckhof; ML de Kam; GL Feiss; Errol Prens; J Burggraaf; R Rissmann; Martijn van Doorn

doi:10.1111/cts.12792

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial

T Kolk, H van der Wall, GK Hogendoorn, R Rijneveld, S Luijten, DCJG van Alewijk, EHA van den Munckhof, ML de Kam, GL Feiss, Errol Prens, J Burggraaf, R Rissmann, Martijn van Doorn

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

35 Downloads (Pure)

Original language	English
Pages (from-to)	994-1003
Number of pages	10
Journal	Clinical and Translational Science
Volume	13
Issue number	5
DOIs	https://doi.org/10.1111/cts.12792
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1111/cts.12792

Repub_126759_O-A.pdfFinal published version, 963 KB

Cite this

Kolk, T., van der Wall, H., Hogendoorn, GK., Rijneveld, R., Luijten, S., van Alewijk, DCJG., van den Munckhof, EHA., de Kam, ML., Feiss, GL., Prens, E., Burggraaf, J., Rissmann, R., & van Doorn, M. (2020). Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial. Clinical and Translational Science, 13(5), 994-1003. https://doi.org/10.1111/cts.12792

@article{47740b8380784529965bc09a942885d7,

title = "Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial",

author = "T Kolk and {van der Wall}, H and GK Hogendoorn and R Rijneveld and S Luijten and {van Alewijk}, DCJG and {van den Munckhof}, EHA and {de Kam}, ML and GL Feiss and Errol Prens and J Burggraaf and R Rissmann and {van Doorn}, Martijn",

year = "2020",

doi = "10.1111/cts.12792",

language = "English",

volume = "13",

pages = "994--1003",

journal = "Clinical and Translational Science",

issn = "1752-8054",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

Kolk, T, van der Wall, H, Hogendoorn, GK, Rijneveld, R, Luijten, S, van Alewijk, DCJG, van den Munckhof, EHA, de Kam, ML, Feiss, GL, Prens, E, Burggraaf, J, Rissmann, R & van Doorn, M 2020, 'Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial', Clinical and Translational Science, vol. 13, no. 5, pp. 994-1003. https://doi.org/10.1111/cts.12792

TY - JOUR

T1 - Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial

AU - Kolk, T

AU - van der Wall, H

AU - Hogendoorn, GK

AU - Rijneveld, R

AU - Luijten, S

AU - van Alewijk, DCJG

AU - van den Munckhof, EHA

AU - de Kam, ML

AU - Feiss, GL

AU - Prens, Errol

AU - Burggraaf, J

AU - Rissmann, R

AU - van Doorn, Martijn

PY - 2020

Y1 - 2020

U2 - 10.1111/cts.12792

DO - 10.1111/cts.12792

M3 - Article

C2 - 32315497

SN - 1752-8054

VL - 13

SP - 994

EP - 1003

JO - Clinical and Translational Science

JF - Clinical and Translational Science

IS - 5

ER -